Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Compounding503ainnovation compoundingrevelation pharmageorgia

Innovation Compounding opens new 503A facility in Kennesaw, Georgia

The pharmacy, part of the Revelation Pharma network, held a ribbon-cutting on Oct. 15.

MH
By Maren Holt · Senior Reporter, GLP-1
Oct 20 15:14 ETSource: Marietta Daily Journal

The wire

  1. 01Innovation Compounding, a 503A compounding pharmacy in the Revelation Pharma national network, marked the grand opening of its Kennesaw facility with an Oct. 15 ribbon-cutting.
  2. 02503A capacity expansion is worth tracking for prescribers and operators sourcing patient-specific compounded preparations.
  3. 03The report does not specify the facility's size, product lines or whether peptide preparations are part of its output.

From the source

Innovation Compounding celebrates grand opening in Kennesaw

Innovation Compounding, a 503A compounding pharmacy and member of the Revelation Pharma national network that serves patients across the country, celebrated the grand opening of its new Kennesaw facility with a ribbon-cutting ceremony on Oct. 15.

Read at mdjonline.com
PeptiPrescribed peptides from $99/moSee all →